CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Societe De Therapeutique Marocaine Company Snapshot
Societe De Therapeutique Marocaine operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Societe De Therapeutique Marocaine with three other pharmaceutical manufacturers in Africa: Glaxo Smithkline Consumer Nig PLC of Nigeria (2016 sales of 14.38 billion Naira [US$47.18 million] ), Promopharm SA (529.79 million Moroccan Dirhams [US$54.34 million] ), and Societe Adwya SA which is based in Tunisia (84.65 million Dinar [US$34.68 million] ).

Sales Analysis. Societe De Therapeutique Marocaine reported sales of 1.33 billion Moroccan Dirhams (US$136.03 million) for the year ending December of 2016. This represents an increase of 14.8% versus 2015, when the company's sales were 1.16 billion Moroccan Dirhams. Sales at Societe De Therapeutique Marocaine have increased during each of the previous five years (and since 2011, sales have increased a total of 41%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Societe De Therapeutique Marocaine
  Stock Performance Chart for Societe De Therapeutique Marocaine
 
  Stock Data: Recent Stock Performance:
  Current Price (4/21/2017): 1,250.00
(Figures in Moroccan Dirhams)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Societe De Therapeutique Marocaine Key Data:
  Ticker: SOT Country: Morocco
  Exchanges: CAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,326,382,535
(Year Ending Jan 2017).
Employees: N/A
  Currency: Moroccan Dirhams Market Cap: 2,250,000,000
  Fiscal Yr Ends: December Shares Outstanding: 1,800,000
  Share Type: Ordinary Closely Held Shares: 1,577,344
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.